Skip to content

QuickVue iFOB Test

by Quidel Corp. 5 variants

QuickVue iFOB Test (20194) is a Class II device made by Quidel Corp., cleared under FDA 510(k) K021423 on 17 Jun 2002 and listed in FDA GUDID since 15 Sep 2016 (UDI-DI 30014613201946), active as of 23 Oct 2026.

Active United States. Also listed in GUDID (US).

510(k)

Valid until

No expiry

510(k) clearance is not time-limited

FDA recalls

None found

in data synced 23 Oct 2026

Documents

510(k) K021423

FDA submission, from GUDID

Trust

Unverified

Source GUDID, synced 23 Oct 2026.

Regulatory status

as of registry sync 23 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesGUDID listing Number30014613201946 UDI-DI Date15 Sep 2016ListedStatusListed GUDID: in commercial distribution
United StatesFDA 510(k)SESE from GUDID Substantially Equivalent · Abbreviated NumberK021423 Date17 Jun 2002DecidedStatusActive

Official records

Across registries

2 registries list this device

  • FDA 510(k) K021423 decided 17 Jun 2002 Active
  • FDA GUDID UDI-DI 30014613201946 listed 15 Sep 2016 Listed

Timeline

2 dated events

  1. Cleared FDA 510(k) K021423
  2. Listed FDA GUDID 30014613201946

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA 510(k) Active

Specification

GUDID

Trade name
QuickVue
Generic name
Faecal occult blood IVD, kit, rapid ICT, clinical
Model / Ref / Catalog
iFOB Test, 20194
Primary DI / UDI-DI
30014613201946
510(k) Number
FDA product code
KHE
GMDN term
Faecal occult blood IVD, kit, rapid ICT, clinical
Device class
Class II
Regulation number
864.6550
GUDID distribution status
In Commercial Distribution

Similar devices

Other devices filed under FDA product code KHE (REAGENT, OCCULT BLOOD).

Other devices from Quidel Corp.

See all devices from Quidel Corp. →

Properties

  • Single use
  • Prescription use
  • Convenience kit
  • Lot / batch number
  • Expiration date
Other properties (10, all answered No)